No. |
Product Name |
CAS No. |
Spec |
Price |
|
| QA090227 |
Apixaban impurity 7 (BMS-589145) |
NA |
| 25mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| U-84A |
cis-4,7,10,13,16,19-Docosahexaenoic acid (DHA) |
6217-54-5 |
|
|
| U-99A |
cis-5,8,11,14,17-Eicosapentaenoic acid (EPA) |
10417-94-4 |
|
|
| QL222021 |
Lovastatin Dimer |
149756-62-7 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
| 100mg |
Inquiry |
|
|
| QC060950 |
Cefixime-13C-15N |
79350-37-1(unlabeled) |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| QA150950 |
N-Desthyl Amodiaquine-D5 |
1216894-33-5 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| CM-3068 |
Fucoxanthin ≥98% |
3351-86-8 |
| 5mg |
Inquiry |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| TA-024 |
Azithromycin dihydrate ≥95.0% |
117772-70-0 |
|
|
| TA-074 |
Azithromycin impurity E |
612069-27-9 |
|
|
| TA-075 |
Azithromycin impurity F (3’-N-demethyl-3’-N- formylazithromycin) |
612069-28-0 |
|
|
| TA-083 |
Azithromycin impurity G (3’-N-demethyl-3’-N-[(4-methylphenyl)sulphonyl]azithromycin) |
612069-31-5 |
|
|
| TA-084 |
Azithromycin impurity H (3’-N-[[4-(acetylamino)phenyl]sulphonyl]-3’-N-demethylazithromycin) |
612069-30-4 |
|
|
| TA-081 |
Azithromycin impurity I (3’-N-demethylazithromycin) |
172617-84-4 |
|
|
| TA-082 |
Azithromycin impurity J (decladinosyl azithromycin) |
117693-41-1 |
|
|
| TA-078 |
Azithromycin impurity L (azithromycin 3’-N-oxide) |
90503-06-3 |
|
|
| TB-015 |
Bacitracin A ≥99.0% |
22601-59-8 |
|
|
| TB-016 |
Bacitracin B1 ≥99.0% |
57762-79-5 |
|
|
| TB-017 |
Bacitracin B2 ≥99.0% |
N/A |
|
|
| TB-021 |
Bacitracin F ≥99.0% |
22601-63-4 |
|
|
| TB-018 |
Bacitracin Xa ≥99.0% |
N/A |
|
|
